Reply to Comment on “Market Exclusivity for Drugs with Multiple Orphan Approvals (1983–2017) and Associated Budget Impact in the US”

William V. Padula, Sonal Parasrampuria, Mariana P. Socal, Rena M. Conti, Gerard F. Anderson

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1375-1376
Number of pages2
JournalPharmacoEconomics
Volume38
Issue number12
DOIs
StatePublished - Dec 2020

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this